N. Lavallee

Comparative study of extended release albuterol sulfate and long-acting inhaled salmeterol xinafoate in the treatment of nocturnal asthma.

R. Martin, M. Kraft, J. Sublett, 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Intranasal Loteprednol Etabonate in Healthy Male Subjects: Pharmacokinetics and Effects on Endogenous Cortisol

H. Derendorf, R. Hermann, G. Hochhaus, 2004, Journal of clinical pharmacology.

Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit

N. Krug, J. Hohlfeld, R. Hermann, 2005, Allergy.

Tri-Nasal Triamcinolone Acetonide Nasal Spray 200 and 400 μg qd versus Placebo and Nasacort Triamcinolone Acetonide Nasal Aerosol 440 μg qd in Patients Suffering from Seasonal Allergic Rhinitis during the Grass Season

R. Dockhorn, P. Korenblat, W. Lumry, 1998 .

Tri-Nasal triamcinolone acetonide nasal spray 200 and 400 micrograms qd versus placebo and Nasacort triamcinolone acetonide nasal aerosol 440 micrograms qd in patients suffering from seasonal allergic rhinitis during the grass season.

R. Dockhorn, G. Shapiro, E. Bronsky, 1998, American journal of rhinology.

Maladaptive behaviors in individuals with Angelman syndrome

L. Bird, R. Hundley, S. Peters, 2019, American journal of medical genetics. Part A.

A comparison of 5-day courses of dirithromycin and azithromycin in the treatment of acute exacerbations of chronic obstructive pulmonary disease.

B. Celli, J. Hanrahan, F. Gomez, 2003, Clinical therapeutics.

A Pharmacokinetic Comparison of Two Oral Liquid Glucocorticoid Formulations

M. B. Scott, S. Szefler, John C. Seiner, 1997, Pharmacotherapy.

Evaluation of the onset and duration of effect of azelastine eye drops (0.05%) versus placebo in patients with allergic conjunctivitis using an allergen challenge model.

M. Friedlaender, H. Russell, J. Harris, 2000, Ophthalmology.

Efficacy of Disease-Modifying Therapies in Relapsing Remitting Multiple Sclerosis: A Systematic Comparison

M. Freedman, A. al‐Sabbagh, R. Bennett, 2008, European Neurology.

Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study.

L. Dubé, T. Casale, H. Nelson, 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

Efficacy and safety of azelastine in allergic conjunctivitis in children

J. Hanrahan, A. Sabbah, U. Petzold, 2002 .